Graft‐versus‐host disease (GvHD) is a common and often serious complication of
hematopoietic stem cell transplantation. There are two major forms of GvHD: an acute form …

Extracorporeal photopheresis is effective treatment for chronic refractory graft-versus-host
disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Chronic graft-versus-host disease (cGVHD) affects> 50% of hematopoietic stem cell
transplant patients. Extracorporeal photopheresis (ECP), an immunomodulatory therapy …

The investigation of extracorporeal photopheresis (ECP) plus standard of care (SoC)(SoC+
ECP) in chronic graft-versus-host disease (cGVHD) within prospective, randomized clinical …

Extracorporeal photopheresis (ECP) is one of the most used and established therapies for
steroid‐refractory graft‐vs‐host disease (GvHD), with a good effect to side effect profile. In …

Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing
agent 8-methoxypsoralen and UV-A radiation has been shown to be effective in the …

Background Infections are common with significant mortality and morbidity in patients with
graft‐versus‐host disease (GvHD). Extracorporeal photopheresis (ECP) is an advantageous …

Extracorporeal photopheresis (ECP) has been used for treatment of steroid-refractory graft
versus host disease (GVHD) with encouraging results. Although its exact mechanism of …

Graft-versus host disease (GVHD) is one of the major limitations to allogeneic hematopoietic
stem cell transplantation (HCT). Although corticosteroids with calcineurin inhibitors are …

Background: Chronic graft-versus-host disease (cGvHD) is a major complication after
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) is an …